These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7848900)

  • 1. Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.
    Santarelli P; Biscione F; Natale A; Manzoli A; Lanza GA
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):653-8. PubMed ID: 7848900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of myocardial ischemia in coronary artery disease: effect of drug regime and irregular dosing in the CAPE II trial.
    Deanfield JE; Detry JM; Sellier P; Lichtlen PR; Thaulow E; Bultas J; Brennan C; Young ST; Beckerman B;
    J Am Coll Cardiol; 2002 Sep; 40(5):917-25. PubMed ID: 12225716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of oral diltiazem before and after beta blockade.
    Kumar K; Bajaj R; Kaul U; Bahl VK
    Clin Cardiol; 1991 Apr; 14(4):317-20. PubMed ID: 2032407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patients.
    Mitchell LB; Jutzy KR; Lewis SJ; Schroeder JS; Mason JW
    Am Heart J; 1982 Jan; 103(1):57-66. PubMed ID: 7055046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Centralised European Studies in Angina Research (CESAR) Investigators.
    Knight CJ; Fox KM
    Am J Cardiol; 1998 Jan; 81(2):133-6. PubMed ID: 9591893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
    Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.
    Davies RF; Habibi H; Klinke WP; Dessain P; Nadeau C; Phaneuf DC; Lepage S; Raman S; Herbert M; Foris K
    J Am Coll Cardiol; 1995 Mar; 25(3):619-25. PubMed ID: 7860905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open comparative study to assess the efficacy and safety of two calcium antagonists: amlodipine and diltiazem in the treatment of symptomatic myocardial ischemia.
    Canale C; Terrachini V; Masperone MA; Caponnetto S
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S57-60. PubMed ID: 16296712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
    Davies GJ; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the effect of the calcium antagonist nifedipine, the beta receptor blockers acebutolol and propranolol and their combination on electrophysiologic parameters in the human].
    Vey G; Wiese KH; Schramm A; Walter J
    Z Kardiol; 1984 Feb; 73(2):101-5. PubMed ID: 6719982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the acute hemodynamic and electrophysiologic effects of intravenous amlodipine alone and in combination with a beta-blocker in patients with angina pectoris.
    Vetrovec GW; Plumb V; Epstein AE; Kay GN
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S29-33. PubMed ID: 7522285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
    Poulter NR; Dobson JE; Sever PS; Dahlöf B; Wedel H; Campbell NR;
    J Am Coll Cardiol; 2009 Sep; 54(13):1154-61. PubMed ID: 19761936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exercise hemodynamic comparison of verapamil, diltiazem, and amlodipine in coronary artery disease.
    Silke B; Goldhammer E; Sharma SK; Verma SP; Taylor SH
    Cardiovasc Drugs Ther; 1990 Apr; 4(2):457-63. PubMed ID: 2149514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker. Amlor-Holter Study Investigators.
    Madjlessi-Simon T; Fillette F; Mary-Krause M; Lechat P; Jaillon P
    Eur Heart J; 1995 Dec; 16(12):1780-8. PubMed ID: 8682007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hemodynamic and electrophysiologic effects of propranolol in patients receiving diltiazem.
    Wolfe CL; Tilton GD; Hillis LD; el Ashram N; Winniford MD
    Am J Cardiol; 1985 Jul; 56(1):47-50. PubMed ID: 4014039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate-dependent effects of diltiazem on human atrioventricular nodal properties.
    Talajic M; Lemery R; Roy D; Villemaire C; Cartier R; Coutu B; Nattel S
    Circulation; 1992 Sep; 86(3):870-7. PubMed ID: 1516199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.
    Glesby MJ; Aberg JA; Kendall MA; Fichtenbaum CJ; Hafner R; Hall S; Grosskopf N; Zolopa AR; Gerber JG;
    Clin Pharmacol Ther; 2005 Aug; 78(2):143-53. PubMed ID: 16084849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome].
    Kalyuzhin VV; Teplyakov AT; Pushnikova EY; Bespalova LD; Kalyuzhina EV; Kolesnikov RN
    Ter Arkh; 2013; 85(5):68-72. PubMed ID: 23819342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.